Lantheus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lantheus and other ETFs, options, and stocks.

About LNTH

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. 

CEO
Mary Anne Heino
CEOMary Anne Heino
Employees
1,193
Employees1,193
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
1956
Founded1956
Employees
1,193
Employees1,193

LNTH Key Statistics

Market cap
6.59B
Market cap6.59B
Price-Earnings ratio
24.40
Price-Earnings ratio24.40
Dividend yield
Dividend yield
Average volume
2.51M
Average volume2.51M
High today
$101.25
High today$101.25
Low today
$100.73
Low today$100.73
Open price
$101.05
Open price$101.05
Volume
1.03M
Volume1.03M
52 Week high
$111.86
52 Week high$111.86
52 Week low
$49.67
52 Week low$49.67

Stock Snapshot

Lantheus(LNTH) stock is priced at $101.11, giving the company a market capitalization of 6.59B. It carries a P/E multiple of 24.40.

On 2026-08-07, Lantheus(LNTH) stock moved within a range of $100.73 to $101.25. With shares now at $101.11, the stock is trading +0.4% above its intraday low and -0.1% below the session's peak.

Trading volume for Lantheus(LNTH) stock has reached 1.03M, versus its average volume of 2.51M.

The stock's 52-week range extends from a low of $49.67 to a high of $111.86.

The stock's 52-week range extends from a low of $49.67 to a high of $111.86.

LNTH News

Investing.com 1d
Lantheus Holdings Inc earnings beat by $0.26, revenue topped estimates - Investing.com

...

Lantheus Holdings Inc earnings beat by $0.26, revenue topped estimates - Investing.com
TipRanks 1d
Lantheus reports Q2 adjusted EPS $1.55, consensus $1.30

Reports Q2 revenue $388.2M, consensus $363.23M. The company said, “In addition, and as previously announced, Lantheus (LNTH) entered into a definitive agreement...

TipRanks 3d
Curium to Acquire Lantheus, Taking Company Private

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Analyst ratings

58%

of 12 ratings
Buy
33.3%
Hold
58.3%
Sell
8.3%

More LNTH News

Simply Wall St 4d
Lantheus Stock Still Looks Below Fair Value Despite Curium Deal

Lantheus Holdings stock has delivered very strong returns over the past few years, yet the current price sits close to the agreed cash offer from Curium, which...

Lantheus Stock Still Looks Below Fair Value Despite Curium Deal
Benzinga 4d
Analyst Calls Curium's $8 Billion Lantheus Buyout An 'Excellent Outcome' For Shareholders

Kate Briant, Chair of Curium’s Board of Directors and a Senior Partner at CapVest, said the acquisition reflects the firm’s confidence in the long-term growth o...

Analyst Calls Curium's $8 Billion Lantheus Buyout An 'Excellent Outcome' For Shareholders
The Wall Street Journal 4d
Lantheus Holdings to Be Acquired for Initial $6.7 Billion

Lantheus said it worked with its financial advisers to conduct a comprehensive evaluation of its strategic options, including outreach to multiple third parties...

Lantheus Holdings to Be Acquired for Initial $6.7 Billion

People also own

Based on the portfolios of people who own LNTH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.